News tagged with appetite suppressant

Cometriq approved for rare thyroid cancer

(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.

Nov 29, 2012
popularity not rated yet | comments 0

US regulators to decide on new weight loss drug

US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.

Jul 17, 2012
popularity not rated yet | comments 0

FDA to decide on Qnexa obesity drug in July

US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.

Apr 10, 2012
popularity not rated yet | comments 0